<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100724'>Thrombophilia</z:hpo> can result from either inherited or acquired conditions </plain></SENT>
<SENT sid="1" pm="."><plain>We describe a teenager who developed extensive <z:mp ids='MP_0005048'>thrombosis</z:mp> requiring aggressive and prolonged anticoagulation </plain></SENT>
<SENT sid="2" pm="."><plain>Laboratory evaluation revealed an acquired <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, consistent with the <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome (APS) </plain></SENT>
<SENT sid="3" pm="."><plain>DNA analysis revealed inherited thrombophilic mutations in the factor V and <z:chebi fb="13" ids="29357,29358">methylene</z:chebi> <z:chebi fb="0" ids="20506,26907">tetrahydrofolate</z:chebi> reductase genes </plain></SENT>
<SENT sid="4" pm="."><plain>We believe that the combination of inherited and acquired hypercoagulable conditions affected her therapeutic response to <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy </plain></SENT>
<SENT sid="5" pm="."><plain>Inherited thrombophilic DNA mutations may contribute to the <z:hpo ids='HP_0100724'>hypercoagulability</z:hpo> observed in patients with acquired thrombophilic conditions such as APS and <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
</text></document>